224 related articles for article (PubMed ID: 10722532)
1. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?
Yellon DM; Baxter GF
Heart; 2000 Apr; 83(4):381-7. PubMed ID: 10722532
[No Abstract] [Full Text] [Related]
2. Protection of the myocardium during ischemia and reperfusion : Na(+)/H(+) exchange inhibition versus ischemic preconditioning.
Avkiran M
Circulation; 1999 Dec 21-28; 100(25):2469-72. PubMed ID: 10604882
[No Abstract] [Full Text] [Related]
3. FR183998, a Na+/H+ exchange inhibitor, suppresses both IL-8 content and myocardial infarct size in a cardiac ischaemia-reperfusion model in rats.
Ohara F; Ohkubo K; Maeda K; Seki J; Goto T
J Pharm Pharmacol; 2002 Feb; 54(2):263-8. PubMed ID: 11848290
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection: emerging pharmacotherapy.
Gumina RJ; Jahangir A; Gross GJ; Terzic A
Expert Opin Pharmacother; 2001 May; 2(5):739-52. PubMed ID: 11336619
[TBL] [Abstract][Full Text] [Related]
5. What's new in salvage of the ischemic myocardium: estrogen postconditioning.
Babiker FA; Joseph S; Juggi JS
Med Princ Pract; 2011; 20(6):495-6. PubMed ID: 21986004
[No Abstract] [Full Text] [Related]
6. A symposium: sodium-hydrogen exchange inhibition. Introduction.
Théroux P
Am J Cardiol; 1999 May; 83(10A):1G-2G. PubMed ID: 10482173
[No Abstract] [Full Text] [Related]
7. Reperfusion injury and ischemic preconditioning: two sides of a coin?
Fiolet JW
Cardiovasc Res; 2000 Nov; 48(2):185-7. PubMed ID: 11054464
[No Abstract] [Full Text] [Related]
8. Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.
Bencsik P; Gömöri K; Szabados T; Sántha P; Helyes Z; Jancsó G; Ferdinandy P; Görbe A
Br J Pharmacol; 2020 Dec; 177(23):5336-5356. PubMed ID: 32059259
[TBL] [Abstract][Full Text] [Related]
9. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
10. Protection of the myocardial cell during ischemia.
Théroux P
Am J Cardiol; 1999 May; 83(10A):3G-9G. PubMed ID: 10482174
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
[TBL] [Abstract][Full Text] [Related]
12. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
13. [Cardiological options for acute protection of the reperfused myocardium].
Breuckmann F; Heusch G; Erbel R; Philipp S
Dtsch Med Wochenschr; 2008 Mar; 133(12):591-4. PubMed ID: 18335391
[No Abstract] [Full Text] [Related]
14. In vivo models of myocardial ischemia and reperfusion injury: application to drug discovery and evaluation.
Black SC
J Pharmacol Toxicol Methods; 2000; 43(2):153-67. PubMed ID: 11150743
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
16. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the safety and efficacy of TY-51924 in patients with ST elevated acute myocardial infarction - Early phase II first in patient pilot study.
Takayama T; Kimura K; Fukuzawa S; Hirayama H; Sone T; Ueda Y; Uematsu M; Ishihara M; Nakao K; Matsumoto N; Kosuge M; Hiro T; Asakura M; Kaneko A; Yokoi T; Hirayama A
J Cardiol; 2016 Feb; 67(2):162-9. PubMed ID: 25982669
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection: chances and challenges of its translation to the clinic.
Heusch G
Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
[TBL] [Abstract][Full Text] [Related]
19. Role of preconditioning in cardiac surgery.
Perrault LP; Menasché P
Basic Res Cardiol; 1997; 92 Suppl 2():54-6. PubMed ID: 9457375
[No Abstract] [Full Text] [Related]
20. [The role of free radicals in the myocardial reperfusion injuries and in the development of endogenous adaptation].
Rőth E
Orv Hetil; 2015 Nov; 156(47):1908-11. PubMed ID: 26568105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
